This article is a correction to:
Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis
Yao Wang†
Zhi-ning Fan- Digestive Endoscopy Department, Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
A Corrigendum on:
Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis
by Wang Y, Zhuang H, Jiang X-h, Zou R-h, Wang H-y and Fan Z-n (2023) Front. Immunol. 14:1162458. doi: 10.3389/fimmu.2023.1162458
In the published article, there was an error in the Funding statement. We did not introduce or acknowledge the funding source(s) for this research in the article. The correct Funding statement appears below.
Funding
This research was funded by the Nanjing Municipal Science and Technology Plan Project (202205052), the GSKY20220109 Scientific Research Project of Gu Su College, Nanjing Medical University, the Nanjing Municipal Science and Technology Plan Project (202110014), the Social Development Program of Jiangsu Provincial Department of Science and Technology (BE2022704), and the National Natural Science Foundation of China (82000621).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: ulcerative colitis, microarray, biomarker, genomics, bioinformatics
Citation: Wang Y, Zhuang H, Jiang X-h, Zou R-h, Wang H-y and Fan Z-n (2023) Corrigendum: Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis. Front. Immunol. 14:1323997. doi: 10.3389/fimmu.2023.1323997
Received: 18 October 2023; Accepted: 07 November 2023;
Published: 14 November 2023.
Edited by:
Frontiers in Immunology Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Wang, Zhuang, Jiang, Zou, Wang and Fan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhi-ning Fan, ZmFuemhpbmluZ25tdUBob3RtYWlsLmNvbQ==; Hai-yang Wang, bmFuamluZ3doeUAxMjYuY29t
†These authors have contributed equally to this work